Self-replicating Semliki Forest virus RNA as recombinant vaccine

Current protocols in molecular biology

Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,281 · see citing works

The Dendritic Cell System and its Role in Immunogenicity

Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,659 · see citing works

Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein

Ulmer, J. B., Donnelly, J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318 · see citing works

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,705 · see citing works

Genetic immunization is a simple method for eliciting an immune response

Tang, D.-C. C., DeVit, M. J., & Johnston, S. A. (1992) · Nature · doi:10.1038/356152a0 · Cited by 1,504 · see citing works

MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation

Germain, R. N. (1994) · Cell · doi:10.1016/0092-8674(94)90336-0 · Cited by 1,431 · see citing works

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

Fynan, E. F., Webster, R. G., FULLER, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,116 · see citing works

The Biochemistry and Cell Biology of Antigen Processing and Presentation

Germain, R. N., & Margulies, D. H. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.002155 · Cited by 1,017 · see citing works

A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon

Liljeström, P., & Garoff, H. (1991) · Nature Biotechnology · doi:10.1038/nbt1291-1356 · Cited by 905 · see citing works

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J. W., Jung, G., & Rammensee, H. (1990) · Nature · doi:10.1038/348252a0 · Cited by 771 · see citing works

Gene inoculation generates immune responses against human immunodeficiency virus type 1.

Wang, B., Ugen, K. E., Srikantan, V., Agadjanyan, M. G., Dang, K., Refaeli, Y., Sato, A. I., Boyer, J., Williams, W. V., & Weiner, D. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4156 · Cited by 655 · see citing works

Induction of virus‐specific cytotoxic T lymphocytes <i>in vivo</i> by liposome‐entrapped mRNA

Martinon, F., Krishnan, S., Lenzen, G., Magné, R., Gomard, E., Guillet, J., Lévy, J., & Meulien, P. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230749 · Cited by 473 · see citing works

In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release

Liljeström, P., Lusa, S., Huylebroeck, D., & Garoff, H. (1991) · Journal of Virology · doi:10.1128/jvi.65.8.4107-4113.1991 · Cited by 452 · see citing works

Vaccination with a Plasmid Vector Carrying the Rabies Virus Glycoprotein Gene Induces Protective Immunity against Rabies Virus

Xiang, Z., Spitalnik, S. L., Tran, M., Wunner, W. H., Cheng, J., & Ertl, H. C. J. (1994) · Virology · doi:10.1006/viro.1994.1105 · Cited by 390 · see citing works

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA

Cox, G. J., Zamb, T. J., & Babiuk, L. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.9.5664-5667.1993 · Cited by 342 · see citing works

Semliki Forest Virus Expression System: Production of Conditionally Infectious Recombinant Particles

Berglund, P., Sjöberg, M., Garoff, H., Atkins, G. J., Sheahan, B. J., & Liljeström, P. (1993) · Nature Biotechnology · doi:10.1038/nbt0893-916 · Cited by 289 · see citing works

T and B memory cells

Sprent, J. (1994) · Cell · doi:10.1016/0092-8674(94)90338-7 · Cited by 278 · see citing works

Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation.

Hahn, C. S., Hahn, Y. S., Braciale, T. J., & Rice, C. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2679 · Cited by 226 · see citing works

Internally located cleavable signal sequences direct the formation of Semliki Forest virus membrane proteins from a polyprotein precursor

Liljeström, P., & Garoff, H. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.147-154.1991 · Cited by 219 · see citing works

Spike protein-nucleocapsid interactions drive the budding of alphaviruses

Suomalainen, M., Liljeström, P., & Garoff, H. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4737-4747.1992 · Cited by 182 · see citing works

Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry.

Salminen, A., Wahlberg, J. M., Lobigs, M., Liljeström, P., & Garoff, H. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.116.2.349 · Cited by 154 · see citing works

Alphavirus expression systems

Liljeström, P. (1994) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(94)90063-9 · Cited by 101 · see citing works

Peptide Binding to Major Histocompatibility Complex Molecules

Barber, L. D., & Parham, P. R. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001115 · Cited by 101 · see citing works

The signal sequence of the p62 protein of Semliki Forest virus is involved in initiation but not in completing chain translocation.

Garoff, H., Huylebroeck, D., Robinson, A., Tillman, U., & Liljeström, P. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.3.867 · Cited by 72 · see citing works

Membrane protein lateral interactions control Semliki Forest virus budding.

Ekström, M., Liljeström, P., & Garoff, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06354.x · Cited by 63 · see citing works

Infectious enveloped RNA virus antigenic chimeras.

London, S., Schmaljohn, A. L., Dalrymple, J. M., & Rice, C. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.207 · Cited by 62 · see citing works

Two mutations in the envelope glycoprotein E2 of semliki forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice

Glasgow, G. M., Sheahan, B. J., Atkins, G. J., Wahlberg, J. M., Salminen, A., & Lilieström, P. (1991) · Virology · doi:10.1016/0042-6822(91)90545-m · Cited by 55 · see citing works

Expression of Proteins Using Semliki Forest Virus Vectors

Liljeström, P., & Garoff, H. (1995) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1620s29 · Cited by 55 · see citing works

In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides

Zhou, X., Berg, L., Abdel‐Motal, U. M., & Jondal, M. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90322-k · Cited by 53 · see citing works

A single amino acid change in the E2 spike protein of a virulent strain of Semliki Forest virus attenuates pathogenicity

Glasgow, G. M., Killen, H. M., Liljeström, P., Sheahan, B. J., & Atkins, G. J. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-3-663 · Cited by 34 · see citing works

Characterization of humoral immunity after DNA injection.

Rhodes, G. H., Abai, A. M., Margalith, M., Kuwahara-Rundell, A., Morrow, J., Parker, S. E., & Dwarki, V. (1994) · PubMed · Cited by 25 · see citing works

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

Turner, J. S., O’Halloran, J. A., Kalaidina, E., Kim, W., Schmitz, A. J., Zhou, J. Q., Lei, T., Thapa, M., Chen, R. E., Case, J. B., et al. (2021) · Nature · doi:10.1038/s41586-021-03738-2 · Cited by 831 · see citing works

Advances in mRNA Vaccines for Infectious Diseases

Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00594 · Cited by 680 · see citing works

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works

mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases

Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507 · see citing works

Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses

Vogel, A. B., Lambert, L., Kinnear, E., Busse, D., Erbar, S., Reuter, K. C., Wicke, L., Perkovic, M., Beissert, T., Haas, H., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.017 · Cited by 501 · see citing works

Self-amplifying RNA vaccines for infectious diseases

Bloom, K., van den Berg, F., & Arbuthnot, P. (2021) · Gene Therapy · doi:10.1038/s41434-020-00204-y · Cited by 487 · see citing works

Replicon-Helper Systems from Attenuated Venezuelan Equine Encephalitis Virus: Expression of Heterologous Genesin Vitroand Immunization against Heterologous Pathogensin Vivo

Pushko, P., Parker, M., Ludwig, G. V., Davis, N., Johnston, R. E., & Smith, J. (1997) · Virology · doi:10.1006/viro.1997.8878 · Cited by 444 · see citing works

DNA and RNA-based vaccines: principles, progress and prospects

Leitner, W. W., Han, Y., & Restifo, N. P. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00271-6 · Cited by 401 · see citing works

Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response

Linares-Fernández, S., Lacroix, C., Exposito, J.-Y., & Verrier, B. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.10.002 · Cited by 376 · see citing works

Three decades of messenger RNA vaccine development

Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100766 · Cited by 342 · see citing works

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

Leitner, W. W., Hwang, L. N., DeVeer, M., Zhou, A., Silverman, R. H., Williams, B. R. G., Dubensky, T. W., Han, Y., & Restifo, N. P. (2002) · Nature Medicine · doi:10.1038/nm813 · Cited by 269 · see citing works

An <i>Alphavirus</i> -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Erasmus, J. H., Khandhar, A. P., O’Connor, M. A., Walls, A. C., Hemann, E. A., Murapa, P., Archer, J., Leventhal, S., Fuller, J. T., Lewis, T. B., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc9396 · Cited by 241 · see citing works

Alphavirus-based expression vectors: strategies and applications.

Frolov, I. V., Hoffman, T. A., Prágai, B. M., Dryga, S. A., Huang, H. V., Schlesinger, S., & Rice, C. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11371 · Cited by 238 · see citing works

Enhancing immune responses using suicidal DNA vaccines

Berglund, P., Smerdou, C., Fleeton, M. N., Tubulekas, L., & Liljeström, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0698-562 · Cited by 229 · see citing works

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

Gómez-Aguado, I., Rodríguez-Castejón, J., Vicente-Pascual, M., Rodríguez‐Gascón, A., Solinís, M. Á., & del Pozo‐Rodríguez, A. (2020) · Nanomaterials · doi:10.3390/nano10020364 · Cited by 224 · see citing works

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines

Liljeqvist, S., & Ståhl, S. (1999) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00107-8 · Cited by 214 · see citing works

Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles

Davis, N., Caley, I. J., Brown, K. W., Betts, M. R., Irlbeck, D. M., McGrath, K. M., Connell, M. J., Montefiori, D. C., Frelinger, J. A., Swanstrom, R. I., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.371-378.2000 · Cited by 201 · see citing works

Current prospects for mRNA gene delivery

Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.016 · Cited by 193 · see citing works

Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer

Dubensky, T. W., Driver, D. A., Polo, J. M., Belli, B., LATHAM, E. M., Ibañez, C. E., Chada, S., Brumm, D., Banks, T. A., Mento, S. J., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.508-519.1996 · Cited by 192 · see citing works

RNA: The new revolution in nucleic acid vaccines

Geall, A. J., Mandl, C. W., & Ulmer, J. B. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.05.001 · Cited by 187 · see citing works

RNA-based vaccines

Ulmer, J. B., Mason, P. W., Geall, A. J., & Mandl, C. W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.060 · Cited by 183 · see citing works

Self-Amplifying mRNA Vaccines

Brito, L. A., Kommareddy, S., Maione, D., Uematsu, Y., Giovani, C., Scorza, F. B., Otten, G. R., Yu, D. L., Mandl, C. W., Mason, P. W., et al. (2014) · Advances in genetics · doi:10.1016/bs.adgen.2014.10.005 · Cited by 182 · see citing works

Alphavirus vectors and vaccination

Rayner, J. O., Dryga, S. A., & Kamrud, K. I. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.360 · Cited by 181 · see citing works

DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector

Hariharan, M. J., Driver, D. A., Townsend, K., Brumm, D., Polo, J. M., Belli, B., Catton, D. J., Hsu, D. S., Mittelstaedt, D., McCormack, J. E., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.950-958.1998 · Cited by 178 · see citing works

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

Fleeton, M. N., Chen, M., Berglund, P., Rhodes, G., Parker, S. E., Murphy, M., Atkins, G. J., & Liljeström, P. (2001) · The Journal of Infectious Diseases · doi:10.1086/319857 · Cited by 157 · see citing works

Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

Cagigi, A., & Loré, K. (2021) · Vaccines · doi:10.3390/vaccines9010061 · Cited by 153 · see citing works

Messenger RNA-based vaccines

Pascolo, S. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1285 · Cited by 152 · see citing works

Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine

Mossman, S. P., Bex, F., Berglund, P., Arthos, J. A., O'Neil, S. P., Riley, D. M., Maul, D. H., Bruck, C., Momin, P., Burny, A., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1953-1960.1996 · Cited by 149 · see citing works

Encapsidation of the Flavivirus Kunjin Replicon RNA by Using a Complementation System Providing Kunjin Virus Structural Proteins in trans

Khromykh, A. A., Varnavski, A. N., & Westaway, E. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5967-5977.1998 · Cited by 142 · see citing works

Self-replicating alphavirus RNA vaccines

Ljungberg, K., & Liljeström, P. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.965690 · Cited by 137 · see citing works

Outcome of Immunization of Cynomolgus Monkeys with Recombinant Semliki Forest Virus Encoding Human Immunodeficiency Virus Type 1 Envelope Protein and Challenge with a High Dose of SHIV-4 Virus

Berglund, P., QUESADA-ROLANDER, M., Putkonen, P., Biberfeld, G., Thorstensson, R., & Liljeström, P. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.1487 · Cited by 135 · see citing works

DNA Vaccines: Technology and Application as Anti-parasite and Anti-microbial Agents

Alarcon, J. B., Waine, G. J., & McManus, D. P. (1999) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60152-9 · Cited by 130 · see citing works

Game changers in science and technology - now and beyond

Betz, U. A. K., Arora, L., Assal, R. A., de Azevedo, H. F. Z., Baldwin, J., Becker, M. S., Bostock, S., Cheng, V. W. T., Egle, T., Ferrari, N., et al. (2023) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2023.122588 · Cited by 146 · see citing works

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

Mandl, C. W., Aberle, J. H., Aberle, S. W., Holzmann, H., Allison, S. L., & Heinz, F. X. (1998) · Nature Medicine · doi:10.1038/4031 · Cited by 124 · see citing works

Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector

Caley, I. J., Betts, M. R., Irlbeck, D. M., Davis, N., Swanstrom, R. I., Frelinger, J. A., & Johnston, R. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3031-3038.1997 · Cited by 122 · see citing works

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 120 · see citing works

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

Berglund, P., Fleeton, M. N., Smerdou, C., & Liljeström, P. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00224-2 · Cited by 117 · see citing works

Vaccines for Venezuelan equine encephalitis

Paessler, S., & Weaver, S. C. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.095 · Cited by 114 · see citing works

A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge

Davis, N., Brown, K. W., & Johnston, R. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3781-3787.1996 · Cited by 111 · see citing works

Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

Asselin‐Paturel, C., Lassau, N., Jm, G., Zhang, J., Gay, F., Bex, F., Hallez, S., Leclère, J., PERONNEAU, P., Mami‐Chouaib, F., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300841 · Cited by 107 · see citing works

Immune responses to DNA vaccines

Kowalczyk, D. W., & Ertl, H. C. J. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050330 · Cited by 105 · see citing works

Mucosal adjuvants and delivery systems for protein‐, DNA‐ and RNA‐based vaccines

Vajdy, M., Srivastava, I. K., Polo, J., Donnelly, J., O’Hagan, D. T., & Singh, M. (2004) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2004.01288.x · Cited by 104 · see citing works

A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression<i>in vivo</i>

Johanning, F. W., Conry, R. M., LoBuglio, A. F., Wright, M., Sumerel, L. A., Pike, M. J., & Curiel, D. T. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.9.1495 · Cited by 99 · see citing works

Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses

Johansson, D. X., Ljungberg, K., Kakoulidou, M., & Liljeström, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029732 · Cited by 98 · see citing works

The molecular pathogenesis of Semliki Forest virus: a model virus made useful?

Atkins, G. J., Sheahan, B. J., & Liljeström, P. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-9-2287 · Cited by 98 · see citing works

A New Strategy in Design of (+)RNA Virus Infectious Clones Enabling Their Stable Propagation in E. coli

Yamshchikov, V. F., Mishin, V. P., & Cominelli, F. (2001) · Virology · doi:10.1006/viro.2000.0793 · Cited by 97 · see citing works

DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade

Giri, M. S., Ugen, K. E., & Weiner, D. B. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.370-389.2004 · Cited by 95 · see citing works

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

Moyo, N., Vogel, A. B., Buus, S., Erbar, S., Wee, E. G., Sahin, U., & Hanke, T. (2019) · Molecular Therapy - Methods &amp; Clinical Development · doi:10.1016/j.omtm.2018.10.010 · Cited by 94 · see citing works

Engineering nanoparticle toolkits for mRNA delivery

Sun, B., Wu, W., Narasipura, E. A., Ma, Y., Yu, C., Fenton, O. S., & Song, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115042 · Cited by 93 · see citing works

Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections

Versteeg, L., Almutairi, M. M., Hotez, P. J., & Pollet, J. B. K. (2019) · Vaccines · doi:10.3390/vaccines7040122 · Cited by 93 · see citing works

Humoral and Cellular Immune Response to RNA Immunization with Flavivirus Replicons Derived from Tick-Borne Encephalitis Virus

Aberle, J. H., Aberle, S. W., Kofler, R. M., & Mandl, C. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15107-15113.2005 · Cited by 91 · see citing works

Alphavirus-Based Vaccines

Lundstrom, K. H. (2014) · Viruses · doi:10.3390/v6062392 · Cited by 91 · see citing works

Rise of the RNA machines – self-amplification in mRNA vaccine design

Comes, J. D. G., Pijlman, G. P., & Hick, T. A. H. (2023) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.05.007 · Cited by 87 · see citing works

A new generation of vaccines based on alphavirus self-amplifying RNA

Ballesteros-Briones, M. C., Silva-Pilipich, N., Herrador, G., Vanrell, L., & Smerdou, C. (2020) · Current Opinion in Virology · doi:10.1016/j.coviro.2020.08.003 · Cited by 87 · see citing works

Recombinant viruses as vaccines against viral diseases

de Souza, A. P. D., Haut, L. H., Reyes‐Sandoval, A., & Pinto, A. R. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000400004 · Cited by 87 · see citing works

Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine

Ward, G. B., Rieder, E. A., & Mason, P. W. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7442-7447.1997 · Cited by 80 · see citing works

Current view on novel vaccine technologies to combat human infectious diseases

Matić, Z., & Šantak, M. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11713-0 · Cited by 80 · see citing works

mRNA vaccines: the most recent clinical applications of synthetic mRNA

Kwon, S., Kwon, M., Im, S., Lee, K., & Lee, H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01381-7 · Cited by 81 · see citing works

Self-Amplifying RNA Approach for Protein Replacement Therapy

Papukashvili, D., Rcheulishvili, N., Liu, C., Ji, Y., He, Y., & Wang, P. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112884 · Cited by 76 · see citing works

Noncytopathic Flavivirus Replicon RNA-Based System for Expression and Delivery of Heterologous Genes

Varnavski, A. N., & Khromykh, A. A. (1999) · Virology · doi:10.1006/viro.1998.9564 · Cited by 74 · see citing works

The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology

Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12584 · Cited by 71 · see citing works

Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy

Caley, I. J., Betts, M. R., Davis, N., Swanstrom, R. I., Frelinger, J. A., & Johnston, R. E. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00142-5 · Cited by 70 · see citing works

Alphavirus vectors for vaccine production and gene therapy

Lundstrom, K. H. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.3.445 · Cited by 67 · see citing works

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

Fleeton, M. N., Sheahan, B. J., Atkins, G. J., & Liljeström, P. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-3-749 · Cited by 67 · see citing works

Alphavirus expression vectors and their use as recombinant vaccines: a minireview

Tubulekas, I., Berglund, P., Fleeton, M. N., & Liljeström, P. (1997) · Gene · doi:10.1016/s0378-1119(96)00679-8 · Cited by 67 · see citing works

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

Fleeton, M. N., Sheahan, B. J., Gould, E. A., Atkins, G. J., & Liljestrm, P. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-5-1189 · Cited by 64 · see citing works

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems

Morris-Downes, M. M., Phenix, K. V., Smyth, J. A., Sheahan, B. J., Liljeqvist, S., MOONEY, D. A., Liljeström, P., Todd, D., & Atkins, G. J. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00428-x · Cited by 60 · see citing works

Comparative Analysis of Humoral Immune Responses to HIV Type 1 Envelope Glycoproteins in Mice Immunized with a DNA Vaccine, Recombinant Semliki Forest Virus RNA, or Recombinant Semliki Forest Virus Particles

Brand, D., Lemiale, F., Turbica, I., Buzelay, L., BRUNET, S., & Barin, F. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.1369 · Cited by 59 · see citing works

Type I Interferons are essential for the efficacy of replicase-based DNA vaccines

Leitner, W. W., Bergmann‐Leitner, E. S., Hwang, L. N., & Restifo, N. P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.059 · Cited by 56 · see citing works

mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo

Cao, Q., Fang, H., & Tian, H. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122628 · Cited by 55 · see citing works

A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation

Kimura, T., Leal, J. M., Simpson, A., Warner, N. L., Berube, B. J., Archer, J. F., Park, S., Kurtz, R., Hinkley, T., Nicholes, K., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.06.017 · Cited by 52 · see citing works

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview

Machado, B. A. S., Hodel, K. V. S., Fonseca, L. M. D. S., Mascarenhas, L. A. B., Andrade, L. P. C. D. S., Rocha, V. P. C., Soares, M. B. P., Berglund, P., Duthie, M. S., Reed, S. G., et al. (2021) · Vaccines · doi:10.3390/vaccines9111345 · Cited by 52 · see citing works

Modified mRNA as a Therapeutic Tool for the Heart

Kaur, K., & Zangi, L. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07051-4 · Cited by 50 · see citing works

Virus-based vectors for human vaccine applications

Polo, J. M., & Dubensky, T. W. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02324-3 · Cited by 48 · see citing works

Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein

Vignuzzi, M., Gerbaud, S., van der Werf, S., & Escriou, N. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-7-1737 · Cited by 47 · see citing works

Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action

Maruggi, G., Ulmer, J. B., Rappuoli, R., & Yu, D. L. (2021) · Current topics in microbiology and immunology · doi:10.1007/82_2021_233 · Cited by 45 · see citing works

Vaccines ‘on demand’: science fiction or a future reality

Ulmer, J. B., Mansoura, M. K., & Geall, A. J. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.996128 · Cited by 45 · see citing works

Nucleic acid vaccines: research tool or commercial reality

Babiuk, L. A., Babiuk, S., Loehr, B. I., & den Hurk, S. V. D. L.-V. (2000) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(00)00198-7 · Cited by 44 · see citing works

RNA Replicons - A New Approach for Influenza Virus Immunoprophylaxis

Zimmer, G. (2010) · Viruses · doi:10.3390/v2020413 · Cited by 43 · see citing works

Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens

Smith, M. L., Corbo, T. A., Bernales, J., Lindbo, J. A., Pogue, G. P., Palmer, K. E., & McCormick, A. A. (2006) · Virology · doi:10.1016/j.virol.2006.08.040 · Cited by 41 · see citing works

Delivery of synthetic mRNAs for tissue regeneration

Steinle, H., Weber, M., Stoppelkamp, S., Große‐Berkenbusch, K., Golombek, S., Weber, M., Çanak-Ipek, T., Trenz, S.-M., Schlensak, C., & Avci‐Adali, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114007 · Cited by 41 · see citing works

Alphaviruses as vectors for gene delivery

Berglund, P., Tubulekas, I., & Liljeström, P. (1996) · Trends in biotechnology · doi:10.1016/0167-7799(96)10019-6 · Cited by 41 · see citing works

The messenger's great message for vaccination

Pascolo, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1000871 · Cited by 40 · see citing works

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future

Perenkov, A. D., Sergeeva, A. D., Vedunova, M. V., & Krysko, D. V. (2023) · Vaccines · doi:10.3390/vaccines11101600 · Cited by 40 · see citing works

Use of Conventional or Replicating Nucleic Acid-Based Vaccines and Recombinant Semliki Forest Virus-Derived Particles for the Induction of Immune Responses Against Hepatitis C Virus Core and E2 Antigens

Vidalin, O., Fournillier, A., Renard, N., Chen, M., Depla, E., Boucreux, D., Brinster, C., Baumert, T. F., Nakano, I., Fukuda, Y., et al. (2000) · Virology · doi:10.1006/viro.2000.0566 · Cited by 39 · see citing works

Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice

Cabrera, A. C., Sáez, D. R., Céspedes, S., Andrews, E. M., & Oñate, A. A. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.016 · Cited by 38 · see citing works

The 'anti-hype' vaccine

DeFrancesco, L. (2017) · Nature Biotechnology · doi:10.1038/nbt.3812 · Cited by 38 · see citing works

Generation of monoclonal antibodies to native human immunodeficiency virus type 1 envelope glycoprotein by immunization of mice with naked RNA

Giraud, A., Ataman‐Önal, Y., Battail‐Poirot, N., Piga, N., Brand, D., Mandrand, B., & Verrier, B. (1999) · Journal of Virological Methods · doi:10.1016/s0166-0934(99)00009-9 · Cited by 36 · see citing works

Sindbis virus vectors for expression in animal cells

Huang, H. V. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80057-7 · Cited by 36 · see citing works

Alphavirus Vectors: Applications for DNA Vaccine Production and Gene Expression

Lundstrom, K. H. (2000) · Intervirology · doi:10.1159/000053992 · Cited by 35 · see citing works

Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development

Phenix, K. V., Wark, K. L., Luke, C. J., Skinner, M. A., Smyth, J. A., Mawhinney, K. A., & Todd, D. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00026-3 · Cited by 34 · see citing works

Alphaviruses as expression vectors

Lundstrom, K. H. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80032-8 · Cited by 32 · see citing works

Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform “Spotty Business”

Schoenly, K. A., & Weiner, D. B. (2007) · Journal of Virology · doi:10.1128/jvi.01634-07 · Cited by 32 · see citing works

Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives

Seregin, A. V., Nistler, R., Borisevich, V., Yamshchikov, G. V., Chaporgina, E., Kwok, C. W., & Yamshchikov, V. F. (2006) · Virology · doi:10.1016/j.virol.2006.07.038 · Cited by 31 · see citing works

Comparative Immunization Study Using RNA and DNA Constructs Encoding a Part of the Plasmodium falciparum Antigen Pf332

Andersson, C., Vasconcelos, N. ‐., Sievertzon, M., Haddad, D. E., Liljeqvist, S., Berglund, P., Liljeström, P., Ahlborg, N., Ståhl, S., & Berzins, K. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00951.x · Cited by 30 · see citing works

A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge

Li, N., Qiu, H., Jian-jun, Z., Li, Y., Wang, M., Lu, B., Han, C.-G., Hou, Q., Wang, Z., Gao, H. J., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.08.020 · Cited by 30 · see citing works

Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primatesPreprint

Erasmus, J. H., Khandhar, A. P., Walls, A. C., Hemann, E. A., O’Connor, M. A., Murapa, P., Archer, J. F., Leventhal, S. S., Fuller, J., Lewis, T. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.28.121640 · Cited by 30 · see citing works

Delivery and Expression of Heterologous Genes in Mammalian Cells Using Self-Replicating Alphavirus Vectors

Karlsson, G. B., & Liljeström, P. (2004) · Humana Press eBooks · doi:10.1385/1-59259-650-9:543 · Cited by 29 · see citing works

Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses

Liu, Y., Li, Y., & Hu, Q. (2023) · Vaccines · doi:10.3390/vaccines11071142 · Cited by 27 · see citing works

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

Zhou, X., Berglund, P., Zhao, H., Liljeström, P., & Jondal, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3009 · Cited by 115 · see citing works

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

Berglund, P., Fleeton, M. N., Smerdou, C., & Liljeström, P. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00224-2 · Cited by 117 · see citing works

Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein

Vignuzzi, M., Gerbaud, S., van der Werf, S., & Escriou, N. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-7-1737 · Cited by 47 · see citing works

Genetic vaccination against acute viral disease

Fleeton, M. N. (1999) · Figshare

Expression of Semliki Forest virus recombinant capsid protein and its in vitro association with auto amplify RNA

Gomes, R. P. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)